Clinical

Dataset Information

0

A Randomized, Controlled, Multicenter Clinical Trial of Kangai Injection in Combination with Chemotherapy XELOX in Treatment of Colorectal Cancer


ABSTRACT: Interventions: Experiment group:Kangai injection 60ml ivgtt D1-14 Q21d, combined with chemotherapy: Eloxatin 130mg/m2 2h ivgtt d1, Xeloda 1000mg/m2 bid po d1-14 Q21d;Control group:Chemotherapy: Eloxatin 130mg/m2 2h ivgtt d1, Xeloda 1000mg/m2 bid po d1-14 Q21d Primary outcome(s): Adverse Reactions Study Design: Randomized parallel controlled trial

DISEASE(S): Colorectal Cancer

PROVIDER: 2674808 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 89641 | ecrin-mdr-crc
| 2090033 | ecrin-mdr-crc
| 2687981 | ecrin-mdr-crc
| 2009842 | ecrin-mdr-crc
| 2009841 | ecrin-mdr-crc
| 2495080 | ecrin-mdr-crc
| 2491836 | ecrin-mdr-crc
| 2047777 | ecrin-mdr-crc
| 2619416 | ecrin-mdr-crc
| 2030953 | ecrin-mdr-crc